1+ hour, 33+ min ago  (578+ words) L. E. K Consulting's report reveals that Chinese biotechs pursue global trials primarily to secure partnerships and leverage their structural advantages in early-stage cell and gene therapy development. At'China Bio Partnering Forum'in Shanghai, China, last month,'Bio Xconomy'sat down with Helen Chen,…...

14+ hour, 31+ min ago  (438+ words) WCG strengthens its AI roadmap with The Contract Network, aiming to simplify site contracting and improve trial efficiency AI-focused drug R&D services firm WCG has bought clinical trial document analysis technology developer The Contract Network. WCG made the acquisition…...

1+ day, 15+ hour ago  (432+ words) FDA pilots real-time trials with Astra Zeneca and Amgen, aiming to streamline drug research and speed regulatory reviews. The US Food and Drug Administration (FDA) says real-time clinical trials (RTCTs)studies in which sponsors report endpoint data to the agency…...

4+ day, 22+ hour ago  (522+ words) Meanwhile, the pharma company faces competition in the oral GLP-1 space as Eli Lilly introduces orforglipron. In a potentially industry-shifting decision, Canada has approved a generic version of Novo Nordisk's semaglutide (Wegovy/Ozempic) for sale in the country. This version…...

1+ week, 17+ hour ago  (448+ words) Finnish firm Faron partners with Parexel to test bexmarilimab in HR-MDS patients across US, UK, and Europe, with results expected in 2027. Finnish drug developer Faron has hired Parexel International to run a Phase II trial of bexmarilimab, its candidate treatment…...

1+ week, 4+ day ago  (405+ words) New clinical trial results show promise for a monoclonal antibody immunosuppressant. Earlier this year, Eledon Pharmaceuticals announced positive results in its clinical transplant trial using its monoclonal antibody (m Ab) based immunosuppressant, tegoprubart (Tego). The trial included a cohort of…...

1+ week, 5+ day ago  (521+ words) Tortugas Neuroscience has launched with a $106 million seed and Series A funding to advance its clinical-stage pipeline. The Massachusetts-based firm will also use the capital to complete Phase II trials for its two lead candidates. Jeff Jonas, CEO of Tortugas,…...

2+ week, 15+ hour ago  (410+ words) Di Me unveils a new initiative to expand direct-to-patient care, focusing on access, affordability, and trust. According to the non-profit, the initiative, "Optimizing Direct-to-Patient (DTP) Strategies for Pharma," will bring "together founding partners across the healthcare ecosystem to realize a…...

2+ week, 1+ day ago  (288+ words) Pathlight strengthens our comprehensive portfolio of diagnostic solutions and reinforces our commitment to transforming cancer care throughout a patient's experience," said Dan Malarek, CEO of Foundation Medicine." MRD is one of the fastest-growing areas within diagnostics, and this technology provides…...

2+ week, 1+ day ago  (533+ words) Belgian biopharmaceutical company UCB has agreed to acquire Neurona Therapeutics in a deal worth up to $1. 15 billion. The deal includes a $650 million upfront payment, with the potential to earn an additional $500 million in milestone payments." At the center of the…...